Related Experiment Videos
HL-A and hypertrophic cardiomyopathy
Insights
Human Leukocyte Antigen (HLA) typing in hypertrophic cardiomyopathy patients revealed a potential link between HLA-A9 and HLA-B7 antigens and familial disease occurrence. Further research is needed to confirm this association.
Area of Science:
- Immunogenetics
- Cardiology
- Human Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition with potential genetic underpinnings.
- Human Leukocyte Antigen (HLA) systems are crucial for immune response and have been implicated in various diseases.
Purpose of the Study:
- To investigate the association between specific HLA antigens and the prevalence of hypertrophic cardiomyopathy in a Japanese cohort.
- To explore the potential role of HLA antigens in the familial transmission of hypertrophic cardiomyopathy.
Main Methods:
- Human Leukocyte Antigen (HLA) typing was performed on 26 unrelated Japanese patients diagnosed with hypertrophic cardiomyopathy.
- HLA antigen frequencies in patients were compared to control populations.
- Two families with multiple affected members were analyzed for specific HLA antigen segregation.
Main Results:
- While several HLA antigens showed higher prevalence in HCM patients, no statistically significant differences were observed compared to controls.
- In familial cases, all affected individuals carried HLA-A9 and HLA-B7.
- Notably, none of the unaffected family members possessed the HLA-B7 antigen.
Conclusions:
- The HLA-A system, specifically the presence of HLA-A9 and HLA-B7, may be associated with the pathogenesis of familial hypertrophic cardiomyopathy.
- These findings suggest a potential genetic susceptibility linked to the HLA locus in certain forms of HCM.
- Further investigation is warranted to elucidate the precise role of HLA in HCM development.
Abstract:
HL-A antigens were determined in 26 unrelated Japanese patients with hypertrophic cardiomyopathy. Several antigens were more common in patients compared with controls, but statistically significant differences were not evidenced. We also studied two families in which many had a hypertrophic cardiomyopathy. All the affected individuals revealed HL-A-A9 and B7, while none among the unaffected family members had HL-A-B7. Our findings suggest that the HLA-A system may play some role in the pathogenesis of hypertrophic cardiomyopathy with familial occurrence.